Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Doximity (DOCS) Cash from Financing Activities (2020 - 2025)

Doximity (DOCS) has disclosed Cash from Financing Activities for 6 consecutive years, with -$203.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 706.27% to -$203.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$400.6 million, a 246.68% decrease, with the full-year FY2025 number at -$131.1 million, up 52.58% from a year prior.
  • Cash from Financing Activities was -$203.5 million for Q4 2025 at Doximity, down from -$30.2 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $552.2 million in Q2 2021 to a low of -$203.5 million in Q4 2025.
  • A 5-year average of -$14.5 million and a median of -$22.5 million in 2024 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 247512.56% in 2021, then tumbled 108418.87% in 2022.
  • Doximity's Cash from Financing Activities stood at $3.8 million in 2021, then tumbled by 79.47% to $779000.0 in 2022, then tumbled by 9791.91% to -$75.5 million in 2023, then skyrocketed by 66.57% to -$25.2 million in 2024, then plummeted by 706.27% to -$203.5 million in 2025.
  • Per Business Quant, the three most recent readings for DOCS's Cash from Financing Activities are -$203.5 million (Q4 2025), -$30.2 million (Q3 2025), and -$137.1 million (Q2 2025).